dihydroergotamine has been researched along with Bilateral Headache in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (36.49) | 18.7374 |
1990's | 24 (32.43) | 18.2507 |
2000's | 7 (9.46) | 29.6817 |
2010's | 12 (16.22) | 24.3611 |
2020's | 4 (5.41) | 2.80 |
Authors | Studies |
---|---|
Calabrò, RS; Casella, C; Militi, D; Raciti, G; Raciti, L | 1 |
Ailani, J; Aurora, SK; Hirman, J; Ray, S; Shrewsbury, SB; Tepper, SJ | 1 |
Aurora, SK; Mallick-Searle, T; Shrewsbury, SB; Starling, AJ | 1 |
Greene, KA | 1 |
Braillon, A | 1 |
Goadsby, PJ; Robbins, NM | 1 |
Charles, A | 1 |
Eller, M; Gelfand, AA; Goadsby, PJ; Riggins, NY; Schankin, C; Shiboski, S | 1 |
Kabbouche, M; Khoury, CK | 1 |
Cowan, RP; DeSouza, DD; O'Hare, M; Woldeamanuel, YW | 1 |
Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM | 1 |
Kelley, BJ; Kunkel, R; Samples, S | 1 |
Johnson, BD; Schenkat, DH; Schulz, LT | 1 |
Peatfield, R | 1 |
Rapoport, AM | 2 |
Goadsby, PJ; Mathias, CJ; Viana, M | 1 |
Banwart, L; Hurtado, TR; Vandenberg, JT; Vinson, DR | 1 |
STIER, C; WILD, H | 1 |
NIESEL, P; OSSENDORF, I; WEIGELIN, E | 1 |
GENNARELLI, L; LENTI, R; VALLESE, P | 1 |
HELBIG, W | 1 |
NOVAK, S; VAJNORSKY, J | 1 |
HAFNER, K; WURM, K | 1 |
PERSICHETTI, C | 1 |
HORTON, BT; PETERS, GA | 1 |
CALDWELL, WG | 1 |
Charles, JA | 1 |
Kabbouche, MA; Linder, SL | 1 |
Fisher, M; Gosy, EJ; Heary, B; Shaw, D | 1 |
Huffmann, G | 1 |
Barone, P; Bonuso, S; Di Stasio, E; Steardo, L | 1 |
Eggers, C | 1 |
Jacobs, H | 1 |
Kaiser, RS; Primavera, JP | 1 |
Henn, V | 1 |
McBeath, JG; Nanda, A | 1 |
Olive, D; Parisi, S; Walker, J | 1 |
Mathew, NT; Ravishankar, K; Sanin, LC | 1 |
Cano, A; Roquer, J | 1 |
Baskin, SM; Queiroz, LP; Rapoport, AM; Sheftell, FD; Siegel, SE; Weeks, RE | 1 |
Ford, KT; Ford, RG | 1 |
Kaplan, B; Swain, RA | 1 |
Finkel, AG; Howard, JF; Mann, JD | 1 |
Howse, D; Pringsheim, T | 1 |
Bøe, MG; Monstad, P | 1 |
Gupta, A; Rothner, AD | 1 |
Angersbach, P; Babej, E; Bollmann, H; Glaser, A; Kolbe, M; Pieschl, D; Schulze, H; von Seck, P | 1 |
Heyck, H | 1 |
Fanchamps, A | 1 |
Benoit, JP; Michelet, FX | 1 |
Hill, RC; van Graffenried, B | 1 |
Barolin, GS | 1 |
Schwalb, H | 1 |
Hommes, OR | 1 |
Kamiyama, Y; Kitajima, T; Miyazaki, T; Onda, M | 1 |
Fletcher, F; Herzeberg, L; Lenman, JA; Victoratos, G | 1 |
Borer, F | 1 |
Wallasch, TM | 1 |
Klapper, JA; Stanton, J | 1 |
Silberstein, JR; Silberstein, SD | 1 |
Remmes, A; Robbins, L | 1 |
Stiller, J | 1 |
Scott, AK | 1 |
Saadah, HA | 2 |
Schulman, EA; Silberstein, SD | 1 |
Scott, G; Ward, TN | 1 |
Hopkins, MM; Schulman, EA; Silberstein, SD | 1 |
Cavanna, M | 1 |
Beyer, HK; Hötzinger, H; Salbeck, R; Toedt, C | 1 |
Conigliaro, S; Filippi, MC; Merati, L; Rosà, R; Taddei, MT | 1 |
Hazelrigg, RL | 1 |
14 review(s) available for dihydroergotamine and Bilateral Headache
Article | Year |
---|---|
Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions.
Topics: Antipsychotic Agents; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Dihydroergotamine; Headache; Humans; Migraine Disorders; Nasal Sprays; Quality of Life; Treatment Outcome; Tryptamines | 2022 |
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.
Topics: Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Headache; Humans; Migraine Disorders; Outcome Assessment, Health Care | 2022 |
INP104: a drug evaluation of a nonoral product for the acute treatment of migraine.
Topics: Dihydroergotamine; Drug Evaluation; Headache; Humans; Migraine Disorders | 2023 |
Management of Primary Headache in the Emergency Department and Inpatient Headache Unit.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Developmental Disabilities; Dihydroergotamine; Disease Management; Emergency Service, Hospital; Headache; Humans; Inpatients; Magnesium Sulfate; Tryptamines | 2016 |
What happens to the old headache medicines?
Topics: Analgesics; Clinical Trials as Topic; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Tryptamines | 2012 |
The therapeutic future in headache.
Topics: Animals; Calcitonin Gene-Related Peptide; Cluster Headache; Dihydroergotamine; Forecasting; Headache; Humans; Transdermal Patch; Tryptamines | 2012 |
Acute treatment of pediatric headache in the emergency department and inpatient settings.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Child; Dihydroergotamine; Drug Therapy, Combination; Emergency Service, Hospital; Headache; Hospitalization; Humans; Metoclopramide; Serotonin Receptor Agonists; Sumatriptan | 2005 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil | 1997 |
Treatment of childhood headaches.
Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Dihydroergotamine; Dopamine Antagonists; Double-Blind Method; Headache; Humans; Infant; Meninges; Migraine Disorders; Models, Theoretical; Patient Care Management; Prostaglandin Antagonists; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tension-Type Headache; Trigeminal Nerve; Vasoconstrictor Agents | 2001 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin | 1975 |
[Drug-induced headache].
Topics: Analgesics; Analgesics, Opioid; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders | 1992 |
Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders | 1992 |
Symptomatic and prophylactic treatment of migraine and tension-type headache.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Drug Therapy, Combination; Ergot Alkaloids; Headache; Humans; Migraine Disorders | 1992 |
[Therapy of headache].
Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Pizotyline; Prednisolone; Prednisone; Vascular Headaches | 1989 |
4 trial(s) available for dihydroergotamine and Bilateral Headache
Article | Year |
---|---|
Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Female; Headache; Humans; Male; Middle Aged; Random Allocation | 1983 |
In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study.
Topics: Dihydroergotamine; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Inpatients; Male; Outpatients; Pain Measurement; Quality of Life; Retrospective Studies; Sick Leave; Treatment Outcome; Vasoconstrictor Agents | 1998 |
[Combined study of Silentan. Test of a headache remedy in general and clinical practice].
Topics: Adult; Aspirin; Caffeine; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Headache; Humans; Male; Middle Aged | 1979 |
Headache as a model for testing mild analgesics.
Topics: Adult; Aminopyrine; Analgesics; Antipyrine; Aspirin; Barbiturates; Caffeine; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Headache; Humans; Male; Placebos; Quinazolines | 1978 |
56 other study(ies) available for dihydroergotamine and Bilateral Headache
Article | Year |
---|---|
The status of intravenous dihydroergotamine for pediatric headache: Status migrainosus and beyond.
Topics: Administration, Intravenous; Child; Dihydroergotamine; Headache; Humans; Migraine Disorders | 2021 |
Letter re: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Author response: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Comment: Outcomes of migraine therapy with IV dihydroergotamine.
Topics: Dihydroergotamine; Female; Headache; Humans; Male; Migraine Disorders | 2016 |
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Causality; Chronic Disease; Comorbidity; Dihydroergotamine; Female; Headache; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Young Adult | 2016 |
Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Headache; Humans; Migraine Disorders | 2016 |
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Adolescent; Adult; Aged; Antiemetics; Dihydroergotamine; Domperidone; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Prospective Studies; Retrospective Studies; Young Adult | 2016 |
PRES following administration of DHE in a patient with unsuspected pheochromocytoma.
Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Headache; Humans; Hypertensive Encephalopathy; Male; Pheochromocytoma; Seizures; Vision Disorders | 2008 |
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; Female; Headache; Humans; Hypertension; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2011 |
Headache currents commentary.
Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan | 2012 |
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Flushing; Headache; Humans; Hypohidrosis; Middle Aged; Migraine Disorders; Nitroglycerin; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
Variations among emergency departments in the treatment of benign headache.
Topics: Adolescent; Adult; Aged; Algorithms; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Binomial Distribution; Cohort Studies; Confidence Intervals; Dihydroergotamine; Diphenhydramine; Drug Therapy, Combination; Emergency Service, Hospital; Female; Headache; Health Maintenance Organizations; Hospitals, Rural; Hospitals, University; Humans; Male; Meperidine; Middle Aged; Migraine Disorders; Practice Guidelines as Topic; Prochlorperazine; Retrospective Studies; Tension-Type Headache; United States | 2003 |
[Clinical experiences with dihydroergotamine (D.H.E.45) with special reference to the therapy of vasomotor headache].
Topics: Cardiovascular Agents; Cluster Headache; Dihydroergotamine; Ergot Alkaloids; Headache; Oxytocics | 1953 |
[Hydergine and DHE 45 therapy of vasomotor headache].
Topics: Cardiovascular Agents; Cluster Headache; Dihydroergotamine; Ergoloid Mesylates; Ergot Alkaloids; Headache; Humans; Oxytocics | 1953 |
[Dihydroergotamine in the headache of hyperthyroid patients].
Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Headache; Hyperthyroidism; Hypothyroidism; Oxytocics | 1961 |
[The treatment of vasomotor headache with special reference to dihydroergotamine].
Topics: Cardiovascular Agents; Cluster Headache; Dihydroergotamine; Ergot Alkaloids; Headache; Oxytocics | 1961 |
[OUR EXPERIENCES WITH DIHYDROERGOTAMINE SPOFA THERAPY IN CEPHALALGIA IN CHILDREN].
Topics: Adolescent; Autonomic Nervous System Diseases; Child; Dihydroergotamine; Ergotamine; Headache; Humans; Infant; Vasomotor System | 1964 |
[Dihydroergotamine treatment of headache].
Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Headache | 1955 |
[Efficacy of dihydroergotamine in ophthalmic hemicrania and glaucoma].
Topics: Dihydroergotamine; Ergot Alkaloids; Eye; Glaucoma; Headache; Humans; Migraine Disorders | 1950 |
Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Headache | 1950 |
Headaches that could spell trouble.
Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Sumatriptan | 2004 |
The treatment of postlumbar puncture headache with DHE-45 (dihydroergotamine).
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Headache; Post-Dural Puncture Headache; Punctures | 1950 |
Outpatient continuous intravenous dihydroergotamine for refractory headache.
Topics: Ambulatory Care; Analgesics, Non-Narcotic; Dihydroergotamine; Headache; Humans; Infusions, Intravenous; Pain, Intractable | 2005 |
Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Retrospective Studies; Treatment Failure | 2007 |
[What is safe in the treatment of headache?].
Topics: Anti-Anxiety Agents; Benzodiazepines; Cerebrovascular Disorders; Cluster Headache; Delayed-Action Preparations; Dihydroergotamine; Dihydroergotoxine; Headache; Humans; Methysergide; Migraine Disorders; Vascular Headaches | 1981 |
[Headache in children].
Topics: Brain Neoplasms; Child; Child, Preschool; Contusions; Dihydroergotamine; Ergotamine; Headache; Humans; Hypertension, Renal; Migraine Disorders; Prognosis; Propranolol; Vascular Headaches | 1984 |
DHE and post-concussion syndrome.
Topics: Brain Concussion; Dihydroergotamine; Headache; Humans; Syndrome | 1995 |
The relationship between locus of control, amount of pre-admission analgesic/ergot overuse, and length of stay for patients admitted for inpatient treatment of chronic headache.
Topics: Attitude to Health; Chronic Disease; Dihydroergotamine; Headache; Humans; Internal-External Control; Length of Stay; Substance-Related Disorders | 1994 |
[The treatment of chronic headache].
Topics: Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chronic Disease; Combined Modality Therapy; Dihydroergotamine; Electroencephalography; Female; Headache; Humans; Magnetic Resonance Imaging; Male; Spinal Puncture; Substance-Related Disorders; Tomography, X-Ray Computed | 1993 |
Use of dihydroergotamine in patients with postconcussion syndrome.
Topics: Adult; Brain Concussion; Dihydroergotamine; Drug Therapy, Combination; Female; Headache; Humans; Male; Memory Disorders; Metoclopramide; Middle Aged; Sleep Wake Disorders; Syndrome | 1994 |
Analgesic rebound headache: experience in a community hospital.
Topics: Adult; Analgesics; Chronic Disease; Dihydroergotamine; Female; Headache; Hospitals, Community; Humans; Hypnotics and Sedatives; Male; Retrospective Studies; Substance Withdrawal Syndrome | 1993 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan | 1996 |
[Ambulatory care of chronic headache secondary to abuse of ergot preparations].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dihydroergotamine; Ergot Alkaloids; Female; Flunarizine; Headache; Humans; Male; Middle Aged; Naproxen; Prospective Studies; Substance-Related Disorders; Time Factors; Vasodilator Agents | 1996 |
Early and transient side effects of repetitive intravenous dihydroergotamine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies | 1996 |
Continuous intravenous dihydroergotamine in the treatment of intractable headache.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Drug Stability; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Pain, Intractable | 1997 |
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Recurrence; Serotonin Receptor Agonists; Sumatriptan | 1998 |
[Transformed migraine--chronic daily headache].
Topics: Adult; Analgesics, Non-Narcotic; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Terminology as Topic; Treatment Outcome; Vasoconstrictor Agents | 1999 |
[Drug therapy of migraine and cluster headache].
Topics: Analgesics; Barbiturates; Caffeine; Dihydroergotamine; Drug Synergism; Ergot Alkaloids; Headache; Histamine H1 Antagonists; Humans; Methysergide; Migraine Disorders; Vascular Headaches | 1975 |
[Treatment with PCR-45-24 of facial pain of vascular origin].
Topics: Dihydroergotamine; Face; Headache; Humans; Pain | 1978 |
[Drug therapy for headache: (author's transl)].
Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders; Neuralgia; Pizotyline; Sleep; Substance-Related Disorders; Tranquilizing Agents | 1977 |
[Letter: Coronary spasm following ergotamine medication].
Topics: Adult; Angina Pectoris; Coronary Disease; Coronary Vessels; Dihydroergotamine; Ergotamine; Headache; Humans; Male; Migraine Disorders | 1975 |
[Vertebrobasilary insufficiency].
Topics: Aged; Arterial Occlusive Diseases; Basilar Artery; Diabetes Complications; Dihydroergotamine; Female; Headache; Humans; Hypertension; Male; Middle Aged; Unconsciousness; Vertebral Artery; Vertigo; Vision Disorders | 1977 |
[Clinical study of dihydroergotamine (DHE-45). 1. Effect in the treatment of vascular headache. 2. Effect on stellate ganglion block].
Topics: Adolescent; Adult; Autonomic Nerve Block; Dihydroergotamine; Ergotamines; Female; Headache; Humans; Male; Middle Aged; Stellate Ganglion; Vascular Headaches | 1976 |
Cluster headaches associated with vascular malformations.
Topics: Cerebral Arteries; Dihydroergotamine; Female; Headache; Humans; Intracranial Arteriovenous Malformations; Middle Aged; Vascular Headaches | 1975 |
[Headaches in gastro-enterology. Their treatment with tonopan (author's transl)].
Topics: Antipyrine; Biliary Tract Diseases; Dihydroergotamine; Drug Combinations; Ergotamines; Headache; Humans; Vascular Headaches | 1976 |
Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches.
Topics: Adult; Aged; Dihydroergotamine; Female; Headache; Humans; Injections, Subcutaneous; Male; Middle Aged; Palliative Care; Recurrence | 1992 |
Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.
Topics: Adult; Aged; Chronic Disease; Dihydroergotamine; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Hospitalization; Humans; Injections, Intravenous; Interviews as Topic; Male; Middle Aged; Prognosis; Substance-Related Disorders; Time Factors | 1992 |
Outpatient repetitive intravenous dihydroergotamine.
Topics: Adult; Ambulatory Care; Dihydroergotamine; Female; Headache; Humans; Injections, Intravenous; Male; Medical Records; Middle Aged; Prospective Studies; Retrospective Studies | 1992 |
Management of acute intractable headaches using i.v. therapy in an office setting.
Topics: Acute Disease; Adult; Ambulatory Care; Antiemetics; Dihydroergotamine; Drug Therapy, Combination; Female; Headache; Humans; Hydrocortisone; Injections, Intravenous; Male; Middle Aged; Pilot Projects | 1992 |
Abortive headache therapy with intramuscular dihydroergotamine.
Topics: Dihydroergotamine; Female; Headache; Humans; Injections, Intramuscular; Male; Recurrence | 1992 |
Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine.
Topics: Adolescent; Adult; Aged; Dihydroergotamine; Drug Therapy, Combination; Female; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Office Visits; Prochlorperazine; Time Factors | 1992 |
Dihydroergotamine suppositories in a headache clinic.
Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Suppositories | 1991 |
Repetitive intravenous DHE in the treatment of refractory headache.
Topics: Chronic Disease; Cluster Headache; Dihydroergotamine; Headache; Humans; Injections, Intravenous; Nausea; Retrospective Studies | 1990 |
[Generalized brain edema and cerebral infarct in ergotamine abuse: imaging by computerized tomography, magnetic resonance tomography and angiography].
Topics: Brain Edema; Cerebral Angiography; Cerebral Infarction; Dihydroergotamine; Dose-Response Relationship, Drug; Female; Headache; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, X-Ray Computed | 1989 |
[Preventive therapy with programmed-release dihydroergotamine in headache in childhood].
Topics: 5-Hydroxytryptophan; Child; Delayed-Action Preparations; Dihydroergotamine; Headache; Humans; Random Allocation | 1987 |
IV DHE-45 relieves exertional cephalgia.
Topics: Adult; Dihydroergotamine; Headache; Humans; Injections, Intravenous; Male | 1986 |